Carregando...
Efficacy of systemic adoptive transfer immunotherapy targeting NY-ESO-1 for glioblastoma
BACKGROUND: Immunotherapy is an ideal treatment modality to specifically target the diffusely infiltrative tumor cells of malignant gliomas while sparing the normal brain parenchyma. However, progress in the development of these therapies for glioblastoma has been slow due to the lack of immunogenic...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Principais autores: | , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4767237/ https://ncbi.nlm.nih.gov/pubmed/26330563 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nov153 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|